A highly bioavailable curcumin formulation ameliorates inflammation cytokines and neurotrophic factors in mice with traumatic brain injury
Chemical Biology & Drug Design · 2024
DOI: 10.1111/cbdd.14439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Ayse Arzu Sakul und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, University of Istanbul Medipol, Istanbul, Turkey. Hauptthemen laut MEDLINE: Curcumin, Brain Injuries, Traumatic, Brain Injuries. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: OmniActive Health Technologies, Türkiye Bilimler Akademisi.
Abstract (Originalsprache)
A novel curcumin formulation increases relative absorption by 46 times (CurcuWIN®) of the total curcuminoids over the unformulated standard curcumin form. However, the exact mechanisms by which curcumin demonstrates its neuroprotective effects are not fully understood. This study aimed to investigate the impact of a novel formulation of curcumin on the expression of brain‐derived neurotrophic factor (BDNF), glial fibrillary acidic protein (GFAP), a main component of the glial scar and growth‐associated protein‐43 (GAP‐43), a signaling molecule in traumatic brain injury (TBI). Mice (adult, male, C57BL/6j) were randomly divided into three groups as follows: TBI group (TBI‐induced mice); TBI + CUR group (TBI mice were injected i.p. curcumin just after TBI); TBI+ CurcuWIN® group (TBI mice were injected i.p. CurcuWIN® just after TBI). Brain injury was induced using a cold injury model. Injured brain tissue was stained with Cresyl violet to evaluate infarct volume and brain swelling, analyzed, and measured using ImageJ by Bethesda (MD, USA). Western blot analysis was performed to determine the protein levels related to injury. While standard curcumin significantly reduced brain injury, CurcuWIN® showed an even greater reduction associated with reductions in glial activation, NF‐κB, and the inflammatory cytokines IL‐1β and IL‐6. Additionally, both standard curcumin and CurcuWIN® led to increased BDNF, GAP‐43, ICAM‐1, and Nrf2 expression. Notably, CurcuWIN® enhanced their expression more than standard curcumin. This data suggests that highly bioavailable curcumin formulation has a beneficial effect on the traumatic brain in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Medicine, University of Istanbul Medipol, Istanbul, Turkey.
- Department of Physiology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
- Regenerative and Restorative Medical Research Center, Experimental Neurology Laboratory, Istanbul Medipol University, Istanbul, Turkey.
- Department of Animal Nutrition, Faculty of Veterinary Medicine, Firat University, Elazig, Turkey.
- Department of Biology, Faculty of Science, Firat University Elazig, Elazig, Turkey.
- Scientific and Clinical Affairs, Research, and Development, OmniActives Health Technologies Inc., Morristown, New Jersey, USA.
ORCID-Profile: Ayse Arzu Sakul, Zeynep Balcikanli, Nilay Ates Ozsoy, Cemal Orhan, Nurhan Sahin, Mehmet Tuzcu, Ertugrul Kilic, Kazim Sahin
Förderung
- OmniActive Health Technologies
- Türkiye Bilimler Akademisi
Zitieren
APA
Sakul, A. A., Balcikanli, Z., Ozsoy, N. A., Orhan, C., Sahin, N., Tuzcu, M., Juturu, V., Kilic, E., & Sahin, K. (2024). A highly bioavailable curcumin formulation ameliorates inflammation cytokines and neurotrophic factors in mice with traumatic brain injury. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14439
Vancouver
Sakul AA, Balcikanli Z, Ozsoy NA, Orhan C, Sahin N, Tuzcu M, et al. A highly bioavailable curcumin formulation ameliorates inflammation cytokines and neurotrophic factors in mice with traumatic brain injury. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14439
BibTeX
@article{Sakul2024,
author = {Sakul, Ayse Arzu and Balcikanli, Zeynep and Ozsoy, Nilay Ates and Orhan, Cemal and Sahin, Nurhan and Tuzcu, Mehmet and Juturu, Vijaya and Kilic, Ertugrul and Sahin, Kazim},
title = {A highly bioavailable curcumin formulation ameliorates inflammation cytokines and neurotrophic factors in mice with traumatic brain injury},
journal = {Chemical Biology & Drug Design},
year = {2024},
doi = {10.1111/cbdd.14439}
}
EUVIMED